FDA Reinstates Medical Device Employees After Controversial Firings Amid Industry Pressure
After mass firings at the FDA, many probationary staffers overseeing medical devices have been reinstated following lobbyist pressure from the medical device industry.
The reversal is the latest example of President Donald Trump and billionaire Elon Musk’s chaotic approach to cost-cutting, which has resulted in several agencies firing, and then scrambling to rehire, employees responsible for nuclear weapons, national parks and other government services.
FDA moves to rehire medical device staffers fired only days earlier, AP says
PBS NewsHour·22d
·ReliableThis source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.Leans LeftThis outlet slightly leans left.The reversal is the latest example of President Donald Trump and billionaire Elon Musk’s chaotic approach to cost-cutting, which has resulted in several agencies firing, and then scrambling to rehire, employees responsible for nuclear weapons, national parks and other government services.
FDA moves to rehire medical device staffers fired only days earlier
Associated Press·22d
·ReliableThis source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.CenterThis outlet is balanced or reflects centrist views.The reversal is the latest in President Donald Trump and billionaire Elon Musk's cost-cutting efforts, which have resulted in several agencies firing and then rehiring employees responsible for nuclear weapons, national parks, and other government services.
FDA Moves to Rehire Medical Device Staffers Fired Only Days Earlier
Newsmax·22d
·Mixed ReliableThis source has a mixed track record—sometimes accurate but also prone to bias, sensationalism, or incomplete reporting.RightThis outlet favors right-wing views.
Summary
In a swift reversal, the FDA has reinstated some probationary staff after a week of firings, primarily from the medical device center. The decision, influenced by lobbying from the medical device industry, aims to mitigate effects on product review efficiency. Although former FDA officials estimate around 700 employees were let go, the rescissions have focused on device reviewers, neglecting other divisions like food and tobacco. The FDA has not disclosed the reinstated numbers, as it continues to navigate cost-cutting measures under the administrations of President Trump and Elon Musk.
Perspectives
No center-leaning sources available for this story.
FAQs
History
- 22d